Molecule intelOpportunity: Strong0Underserved

Phenobarbital Sodium

3 brands · 2 companies · product forms

Opportunity snapshot

Launch attractiveness
58
Market saturation
5
Price room
100
Regulatory risk
0
3
brands
2
companies
Rs 57.03
median price
3
price points
8.76x
price spread
90
confidence %

Who competes here

Top companies by brand count — concentrated market · leader share 67%

2 brands · 67%
1 brands · 33%

Price room

Across observed sources and strengths
CheapestRs 57.03
MedianRs 57.03
Most expensiveRs 499.73
Spread8.76×
Sources: DRAP-official

max/min price ratio 8.76x across 3 trusted points (Rs 57.03-499.73). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(40) + 25% price-variation(100) + 20% low-competition(95) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

2 canonical companies and 3 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 8.76x across 3 trusted points (Rs 57.03-499.73). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.